Institute for Cancer Genetics, and Department of Pathology and Cell Biology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Nat Cancer. 2023 Apr;4(4):564-581. doi: 10.1038/s43018-023-00532-z. Epub 2023 Mar 27.
Although the gain of function (GOF) of p53 mutants is well recognized, it remains unclear whether different p53 mutants share the same cofactors to induce GOFs. In a proteomic screen, we identified BACH1 as a cellular factor that recognizes the p53 DNA-binding domain depending on its mutation status. BACH1 strongly interacts with p53 but fails to effectively bind wild-type p53 or other hotspot mutants in vivo for functional regulation. Notably, p53 acts as a repressor for ferroptosis by abrogating BACH1-mediated downregulation of SLC7A11 to enhance tumor growth; conversely, p53 promotes BACH1-dependent tumor metastasis by upregulating expression of pro-metastatic targets. Mechanistically, p53-mediated bidirectional regulation of BACH1 function is dependent on its ability to recruit the histone demethylase LSD2 to target promoters and differentially modulate transcription. These data demonstrate that BACH1 acts as a unique partner for p53 in executing its specific GOFs and suggest that different p53 mutants induce their GOFs through distinct mechanisms.
尽管已经充分认识到 p53 突变体的功能获得(GOF)作用,但不同的 p53 突变体是否共享相同的辅助因子来诱导 GOF 作用仍不清楚。在蛋白质组学筛选中,我们发现 BACH1 是一种细胞因子,它根据其突变状态识别 p53 DNA 结合域。BACH1 与 p53 强烈相互作用,但在体内无法有效结合野生型 p53 或其他热点突变体以进行功能调节。值得注意的是,p53 通过废除 BACH1 介导的 SLC7A11 下调来抑制铁死亡,从而作为铁死亡的抑制剂来增强肿瘤生长;相反,p53 通过上调促转移靶基因的表达来促进 BACH1 依赖性肿瘤转移。从机制上讲,p53 对 BACH1 功能的双向调节依赖于其招募组蛋白去甲基酶 LSD2 以靶向启动子并差异调节转录的能力。这些数据表明,BACH1 作为 p53 执行其特定 GOF 的独特伙伴发挥作用,并表明不同的 p53 突变体通过不同的机制诱导其 GOF。
Cancer Sci. 2012-4-11
Nat Struct Mol Biol. 2008-12
Carcinogenesis. 2011-11-22
J Exp Clin Cancer Res. 2019-7-15
Med Oncol. 2025-7-22
Cancer Discov. 2025-6-3
Nat Rev Mol Cell Biol. 2025-4-9
Genes (Basel). 2024-12-17
Front Immunol. 2024-11-27
Genes Dev. 2021-4-1
Trends Cell Biol. 2020-6
Trends Cancer. 2020-1
Nat Cell Biol. 2019-11-4